Vincent Castonguay
Chercheur associé
Axe Oncologie
Dernières nouvelles
Communiqués
Le Centre de recherche du CHU de Québec sur le point de doubler son volume d’études cliniques précoces
Centre de recherche
Vers les traitements de demain avec la recherche clinique de phases 1 et 2 en hémato-oncologie
Centre de recherche
Vers les traitements de demain avec la recherche clinique de phases 1 et 2 en hémato-oncologie
Publications
Voir tout-
article Millan B, Ghosh S, Basappa NS, Wood L, Bhindi B, Pouliot F, Breau RH, Finelli A, Bansal RK, Graham J, Bjarnason GA, Bosse D, Castonguay V, Winquist E, Heng DYC, Kollmannsberger CK, Lalani AA
Bone Metastases and Use of Bone Protective Agents for Metastatic Clear Cell Renal Cell Carcinoma: A Contemporary National Real-World Analysis
Clin Genitourin Cancer 24 (4), 2026.
-
article Pouliot F, Lodde M, Besançon M, Castonguay V, Morin-Coulombe A, Fradet V, Fradet Y, Lacombe L, Lévesque É and Marcoux N, Toren P, April G, Arsenault F, Beaulieu A, Singbo N, Veilleux C, Tremblay-Boily M, Tremblay V, Buteau FA, Beauregard JM
Trajectory timelines and treatment efficacy of 177Lu-PSMA-617 radioligand therapy for metastatic castration-resistant prostate cancer: Real-world data from 50 consecutive cases t…
Can Urol Assoc J 20 (6), 2026.
-
article Curry L, Ghosh S, Arenovich E, Tanguay S, Lalani AA, Heng DYC, Bhindi B, Basappa NS, Graham J, Bjarnason GA, Breau RH, Castonguay V, Soulieres D, Pouliot F, Bosse D, Kollmannsberger CK, Finelli A, Fallah-Rad N, Soleimani M
Real-world management and clinical outcomes of first line treatment of advanced renal cell carcinoma in older patients in Canada
J Geriatr Oncol 17 (3), 2026.
Projets
- A Phase II, Multicentre, Open-label,[...]Efficacy and Safety of Datopotamab Deruxtecan(Dato-DXd) as Monotherapy[...]with Anticancer Agents in Patients with Advanced/Metastatic Solid Tumours(TROPION-PanTumor03)(sub-study 6:Bladder), du 2023-12-06 au 2028-12-25